Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₩1,732,709.87, with a 24-hour trading volume of ₩3.74T. The asset's market cap is ₩1.54P, after moving 1.08% in the last day.
Tokenized Eli Lilly And Co is trading at ₩1,733,211.14, with a tokenized market cap of ₩67.41B and a 24-hour trading volume of ₩3.25B. The tokenized asset has moved 0.48% in the past 24 hours.